News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
AstraZeneca PLC (JOBS) Drug Development Head to Retire
November 4, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
LONDON, Nov 4 (Reuters) - AstraZeneca Plc's head of drug development, John Patterson, is to retire from the board of the Anglo-Swedish company next March, marking a key changeover at the top of the group.
Twitter
LinkedIn
Facebook
Email
Print
People
Europe
AstraZeneca
MORE ON THIS TOPIC
Layoff Tracker
Gilead laying off vast majority of Arcellx employees
May 8, 2026
·
51 min read
·
BioSpace Editorial Staff
Earnings
Gilead sets blockbuster bar for Yeztugo’s first full year on the market
May 8, 2026
·
2 min read
·
Tristan Manalac
Pipeline
Ascendis retreats to rare endocrinology wheelhouse as cancer plans falter
May 8, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
FDA pilots AI-informed one-day facility inspections
May 7, 2026
·
2 min read
·
Nick Paul Taylor
